Back in Denmark after >6 weeks in Africa. Time was spent on two trials close to my heart. Here a brief introduction. First, the @EDCTP funded randomised trial of BCG vaccine to health care workers, as a potential bolster against COVID and other infections. edctp.org/projects-2/edc…
It is a two-center trial at #BandimHealthProject in Guinea-Bissau and at @Manhica_CISM in Mozambique. In March, we from Bandim visited the Manhica team, led by Dr. Pedro Aide and Lidia Nhamussua, to align study procedures before the launch of the trial in Mozambique. 
In Guinea-Bissau, we have enrolled ~300 health care workers. Our analyses show that >20% have COVID-19 antibodies; most have not noticed that they were ill. Perhaps this is why many Guineans said no to the COVID-vaccines that were rolled out in April. medrxiv.org/content/10.110…
Photos were certainly more fun before face masks - but here a photo of (part of) the Guinean team, spearheaded by MD Else Ca (left), and featuring among others also PhD student Sebastian Nielsen from @SUND_SDU.
Lastly we prepared for a large randomised trial, to test the effect of providing measles vaccine or BCG vaccine to women before they get pregnant, with the hypothesis that this will improve maternal-child health, as indicated in other studies. frontiersin.org/articles/10.33…
It has been some fantastic weeks - full of work, but it does not matter when it is done in good, warm and reciprocal collaborations, working on interventions that we hope can make a difference. Thanks to all, including our funders, for making this possible.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
